ACTRN12618000130268
Active, not recruiting
Phase 3
A randomised placebo controlled trial of the effect of BLIS probiotic, S. salivarius (K12) on Otitis media (ear infections) and Upper Respiratory Tract Infections amongst 6-24 month old children, as measured by medical record events.
Julian Crane0 sites420 target enrollmentJanuary 30, 2018
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Julian Crane
- Enrollment
- 420
- Status
- Active, not recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Infant must be enrolled in a medical practice, planning to live in the Hutt Valley, Wellington or Christchurch regions for the duration of the study,
Exclusion Criteria
- •Infants with serious medical conditions such as congenital heart conditions, severe immunodeficiency, families who plan to permanently move from the Wellington/Christchurch regions during the 18 month study period. Infants already receiving regular BLIS probiotics or a parent planning to give them to their child, children with a severe dairy allergy.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
The Rhinovirus Study : A bedroom heating intervention to reduce rhinovirus infection in children.ACTRN12614000388617Julian Crane300
Completed
Not Applicable
A randomised placebo-controlled trial of the effect of hormone replacement therapy on dementia and cognitive function in post-menopausal womeObstetrics and gynaecologyUrological and Genital DiseasesPost-menopauseISRCTN55999335Medical Research Council (MRC) (UK)14,240
Completed
Not Applicable
A maternal probiotic intervention for infant allergic disease preventioACTRN12612000196842Dr Kristin Wickens400
Not yet recruiting
Phase 2
Study to assess the impact of insulin on reperfusion injury after skeletal muscle ischaemiaReperfusion injurySLCTR/2014/005Professorial Surgical Unit24
Completed
Phase 3
A randomised controlled trial of the efficacy of a carrageenan nasal spray when taken during a cold in reducing asthma exacerbations as measured by the asthma control questionnaire.Asthma exacerbation during a coldColdsRespiratory - AsthmaInfection - Studies of infection and infectious agentsACTRN12615001166561Julian Crane361